Pregnancy and Cancer: Special Considerations on Maternal and Fetal Implications
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 31
Special Issue Editor
Interests: COVID in pregnancy; prenatal care; fetal medicine; colposcopy; medical law; gynecological oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The Special Issue "Pregnancy and Cancer: Special Considerations on Maternal and Fetal Implications" delves into the complex intersection of cancer diagnosis and treatment during pregnancy. It explores the unique challenges faced by expectant mothers diagnosed with cancer and the implications for both maternal health and fetal development. We aim to cover topics such as the risks associated with various cancer treatments during pregnancy, the importance of multidisciplinary care involving oncologists and obstetricians, and the decision-making process regarding treatment options that balance maternal well-being with fetal safety. Additionally, we would like to touch upon the latest research advancements and guidelines aimed at optimizing outcomes for both mother and baby in these delicate situations emphasizing the need for careful risk assessment and shared decision-making to navigate the delicate balance between treating cancer effectively while minimizing risks to the pregnancy.
Prof. Dr. Liana Pleş
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- pregnancy
- fetus
- chemotherapy
- radiotherapy
- surgery
- targeted therapy
- immunotherapy
